BridgeMD
New treatment option for Chronic Back Pain
Official title Healing Track Clinical Trial
ClinicalTrials.gov ID: NCT06641102
What this study is testing
- What it's testing
- This is a randomized clinical trial to evaluate a digital pain reprocessing therapy (PRT) intervention for chronic back pain (CBP). The purpose of this research is to test whether a new digital treatment for chronic pain works as well as traditional treatments for chronic back pain (CBP).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 70
You may be able to join if
- Aged 21 to 70
- Chronic Back Pain- CBP will be defined according to the criteria established by a recent NIH task force
- Pain duration must be at least 3 months, with back pain being an ongoing problem for at least half the days of the last 6 months. That is, patients...
- Patients must rate pain intensity at 4/10 or greater on the Brief Pain Inventory-Short Form (BPISF) (on the item measuring average pain over the last...
- Participants must also be comfortable and able to communicate via email or text message, as several study measures are collected in this manner.
You likely can't join if
- Back pain associated with compensation or litigation issues as determined by self-report within the past year
- Leg pain is greater than back pain, as this suggests neuropathic pain, which may be less responsive to psychotherapy
- Cauda Equina syndrome, as screened for by self-reported inability to control bowel or bladder function
- Self-reported diagnoses of schizophrenia, multiple personality disorder, or dissociative identity disorder
- Self-reported use of intravenous drugs, due to concerns about infections and subject compliance with experimental protocols
See the full eligibility criteria
- Aged 21 to 70
- Chronic Back Pain- CBP will be defined according to the criteria established by a recent NIH task force
- Pain duration must be at least 3 months, with back pain being an ongoing problem for at least half the days of the last 6 months. That is, patients can meet criteria by either reporting pain every day for the past 3...
- Patients must rate pain intensity at 4/10 or greater on the Brief Pain Inventory-Short Form (BPISF) (on the item measuring average pain over the last week).
- Participants must also be comfortable and able to communicate via email or text message, as several study measures are collected in this manner.
- Able to use a smartphone
- Back pain associated with compensation or litigation issues as determined by self-report within the past year
- Leg pain is greater than back pain, as this suggests neuropathic pain, which may be less responsive to psychotherapy
- Cauda Equina syndrome, as screened for by self-reported inability to control bowel or bladder function
- Self-reported diagnoses of schizophrenia, multiple personality disorder, or dissociative identity disorder
- Self-reported use of intravenous drugs, due to concerns about infections and subject compliance with experimental protocols
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.